Academic Jobs - Home of Higher Ed Logo

A*STAR Breakthrough: Breast Milk IgG Antibodies Train Neonatal Gut Immunity to Prevent Allergies in Singapore

Postet eine Geschichte
312Ansichten
Native advertising — guest articles from $400See packages
Merlion statue with singapore skyline and blue sky
Photo by Gokul on Unsplash

Revolutionary Findings from A*STAR's Singapore Immunology Network

Singapore's Agency for Science, Technology and Research (A*STAR), through its Singapore Immunology Network (SIgN), has unveiled a groundbreaking study revealing how immunoglobulin G (IgG) antibodies in breast milk play a pivotal role in training an infant's gut immune system. Published in the prestigious journal Science on August 14, 2025, the research demonstrates that these maternal antibodies, ingested during the crucial first week of life, help prevent allergic responses to gut antigens later on.

Led by Principal Investigator Dr. Meera Shenoy during her postdoctoral work at the Fred Hutchinson Cancer Center, with key contributions from SIgN researchers, the study used mouse models to pinpoint the mechanisms. It highlights breast milk not just as nutrition but as an immunological tutor, shaping lifelong gut health and potentially averting conditions like food allergies.

This discovery aligns with Singapore's push for biomedical excellence, positioning A*STAR as a global leader in immunology research. For parents and healthcare professionals in Singapore, it underscores the value of breastfeeding in a city-state where early-life immunity is vital amid urban lifestyles.

The Science Behind Maternal IgG and Neonatal Gut Training

IgG, the most abundant antibody in human blood and breast milk, crosses the neonatal gut via the neonatal Fc receptor (FcRn). In the study, researchers deprived newborn mice of maternal IgG to isolate its effects. They found that IgG binds specifically to certain neonatal gut bacteria, forming immune complexes that engage Fc gamma receptors (FcγR) and complement pathways on antigen-presenting cells.

This interaction triggers signaling that programs regulatory T cells (Tregs) and suppresses T follicular helper (Tfh) cells and B cell responses in gut-associated lymphoid tissues (GALT) weeks after weaning. Step-by-step:

  • Ingestion Phase (Day 1-7): Pups consume IgG-rich milk, which targets ~20-30% of gut microbiota.
  • Binding and Complex Formation: IgG coats bacteria, activating effector functions without killing them.
  • Immune Programming: Dendritic cells present antigens tolerogenically, curbing germinal center reactions.
  • Post-Weaning Protection: Reduced IgE production and Th2 responses to new dietary antigens.

Without IgG, mice showed dysbiosis-like immune overreactions, heightening colitis and allergy risks.

Visualization of IgG antibodies binding to neonatal gut bacteria in mouse model

Experimental Evidence: From Mice to Potential Human Insights

The team's rigorous experiments included gnotobiotic mice colonized with defined microbiota. Key data:

  • IgG-fed pups had 50-70% fewer Tfh cells in Peyer's patches post-weaning.
  • Protection against ovalbumin-induced food allergy: 80% reduction in anaphylaxis scores.
  • Dextran sulfate sodium (DSS) colitis model: IgG pups showed 40% less inflammation.
  • Timing critical: IgG after day 7 lost efficacy, emphasizing first-week window.

Flow cytometry revealed strong IgG binding to neonatal-specific bacteria like Bifidobacterium and Lactobacillus, absent in adult guts. This specificity ensures targeted training.Read the full study in Science.

While mouse-based, parallels exist with human data where breastfed infants have lower allergy rates, suggesting translational potential.

Singapore's Rising Allergy Challenge and Breast Milk's Role

In Singapore, food allergies affect up to 5% of older children, with shellfish topping at 5.23%, followed by egg, milk, and peanut—now rising per National University Hospital (NUH) and KK Women's and Children's Hospital (KKH) reports. A 2025 national study confirms increasing cases, contrasting low peanut allergy (0.1-0.3%) despite delayed solids introduction.

Exclusive breastfeeding rates hover at 30-40% at 4 months, below WHO's 6-month goal. This A*STAR work revives breastfeeding advocacy, linking it to gut tolerance amid urbanization's hygiene hypothesis challenges.

Stakeholders like the Health Promotion Board (HPB) could leverage findings for campaigns, reducing allergy burdens estimated at SGD millions in healthcare.

Mechanisms in Detail: Step-by-Step Immune Tolerance Induction

The process unfolds precisely:

  1. Bacterial Coating: Milk IgG, polyclonal against maternal microbiota, binds neonatal strains via Fab regions.
  2. Complex Uptake: FcRn shuttles complexes; FcγRIIB on DCs inhibits activation.
  3. Tolerogenic Signaling: Complement C3b tags promote Treg differentiation, dampening Th2 skewing.
  4. Long-Term Memory: Epigenetic changes in GALT ensure sustained hyporesponsiveness to antigens.

No microbiota composition shift or barrier changes; purely immune modulation. Figures from the paper show dose-dependent protection, with 10µg/day IgG mimicking natural levels.A*STAR highlight.

Implications for Allergy Prevention and Public Health

This positions IgG as a 'gut trainer,' explaining breastfeeding's protective effect against allergies (odds ratio 0.6-0.8 globally). In Singapore, where allergies cost families and systems dearly, it advocates prolonged breastfeeding.

Challenges: Low BF rates, working mothers. Solutions: Policy support via Baby Bonus enhancements, workplace lactation rooms (now 80% coverage).

Broader impacts: Reduced pediatric consultations, lower antibiotic use from dysregulated immunity.

Expert Views and Stakeholder Perspectives

Dr. Shenoy: "Breast milk antibodies precisely control offspring immune-microbiome interactions."

Pediatric allergists at NUH note alignment with clinical observations. SIgN Director: Potential for 'super-formula' via recombinant IgG.

Multi-perspective: Mothers value empowerment; researchers seek funding; policymakers eye cost-savings (allergies ~1% pediatric visits).

Researchers at A*STAR SIgN lab studying breast milk immunity

Future Outlook: From Bench to Formula and Beyond

Next: Human milk IgG profiling, infant cohorts. Trials for IgG-fortified formula could transform non-breastfed care.

In Singapore, integrates with Precision Health Strategy. Global: Addresses allergy epidemics (10-30% kids in West).

Actionable: Promote BF; research microbiota-specific IgG vaccines for mothers.

Explore research jobs at A*STAR to join such breakthroughs.

Careers in Singapore's Biomedical Research Ecosystem

A*STAR SIgN offers postdocs, PIs in immunology. Singapore's ecosystem: SGD1B RIE2025 funding, tax incentives.

Opportunities: Singapore higher ed jobs, research positions. With allergies rising, demand for experts surges.

a statue of a lion spewing water from its mouth

Photo by Edwin Petrus on Unsplash

Conclusion: Empowering Neonatal Health Through Science

A*STAR's IgG discovery illuminates breastfeeding's immunological magic, promising allergy prevention strategies. For Singapore families, it's a call to nurture naturally while advancing formula tech. Stay informed via Rate My Professor for courses, higher ed jobs, and career advice. Future research could redefine infant immunity worldwide.University jobs in biomed await talents driving such impacts.

Porträt von Prof. Marcus Blackwell
Über den Autor

Prof. Marcus BlackwellAutor ansehen

Academic Jobs In House Author

Diskussionen

Sort von:

Seien Sie der Erste, der diesen Artikel kommentiert!

Du bist

Sie werden gebeten, sich anzumelden, bevor Ihr Kommentar veröffentlicht wird.

Neue0 comments

Treten Sie dem Gespräch bei!

Fügen Sie jetzt Ihre Kommentare hinzu!

Haben Sie Ihr Wort

Engagement Ebene

Browse nach Fakultät

Browse nach Thema

Frequently Asked Questions

🍼What is the main finding of the A*STAR breast milk study?

Maternal IgG in breast milk, ingested in the first week, binds neonatal gut bacteria to program immune tolerance, preventing allergic responses post-weaning.

🔬How does IgG train the infant gut immune system?

IgG forms complexes with bacteria, engaging Fc receptors and complement, suppressing Tfh/B cell responses in GALT for microbiota and food antigen tolerance.

👶Is this study relevant to humans?

Mouse model, but mechanisms mirror human BF protection. Human milk IgG profiling next; potential for formula enhancement. Science paper.

🌶️What are food allergy rates in Singapore children?

Shellfish 5.23% older kids; egg/milk/peanut rising. Low peanut (0.2%) despite delayed solids. New 2025 national study tracks trends.

⏰Why is the first week critical?

Neonatal microbiota window; IgG post-day 7 ineffective. Matches human colostrum IgG peak.

🍼Can formula milk replicate this?

Future goal: Recombinant microbiota-specific IgG. Dr. Shenoy eyes supplements for non-BF infants.

📊Singapore breastfeeding stats?

Exclusive BF ~35% at 4 months. HPB promotes; study boosts case for extended BF.

💼Research careers at A*STAR SIgN?

Postdocs, PIs in immunology. Higher ed jobs in Singapore biomed thrive with RIE funding.

🌍Global allergy prevention implications?

Explains hygiene hypothesis; targets 10-30% child allergies in West. Singapore model for Asia.

🚀Next steps for this research?

Human cohorts, IgG probiotics. Impacts policy, formula innovation. Follow Singapore research updates.